Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.

Link to article at PubMed

Related Articles

Early administration of ritonavir-boosted lopinavir could prevent severe COVID-19.

J Infect. 2020 May 27;:

Authors: Klement-Frutos E, Burrel S, Peytavin G, Marot S, Lê MP, Godefroy N, Calvez V, Marcelin AG, Caumes E, Pourcher V, Boutolleau D

Abstract
No specific treatment against SARS-CoV-2 is available after 6 months of COVID-19 worldwide outbreak Antivirals could decrease the viral load and reduce direct and indirect damages of SARSCoV-2 infection Ritonavir-bosted lopinavir is effective against SARS-CoV-2 in vitro Sequential virological and pharmacological monitoring helped to understand the efficacy of ritonavir-boosted lopinavir in a SARS-CoV-2 infected patient Ritonavir-boosted lopinavir could be proposed as early treatment for SARS-CoV-2 infection.

PMID: 32473230 [PubMed - as supplied by publisher]

Leave a Reply

Your email address will not be published.